Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review
Journal Title: International Journal of Stem Cell Research and Transplantation (IJST) - Year 2016, Vol 4, Issue 3
Abstract
Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, development of immunosuppressive agents is the key for successful allograft function. Immunosuppression agents in RT have evolved over the last six decades beginning with total lymphoid irradiation to the currently available immunosuppressive strategies, which have significantly reduced the incidence of acute rejection episodes and improved short-term graft and patient outcomes. However their use is associated with long-term graft dysfunction, hypertension, hyperlipidaemia, diabetes mellitus, infections and malignancies. Chronic antibody-mediated rejection and chronic allograft dysfunction still remain the major problems, often leading to graft loss and shortened long-term graft survival. Immunosuppressive agents are used for induction, maintenance and reversal of established rejection. The use of multidrug regimen tailored to the immunological risk of patient and adverse-effect profile of the drug provides the optimum outcomes.This review focuses on the evolution of immunosuppression agents used in RT over last six decades and highlights the newer agents under investigation.
Authors and Affiliations
Badri Shrestha
Vascular Regenerative Surgery: Promised Land for Tissue Engineers?
Cardiovascular cell therapy is a promising new field for the development of treatments for cardiovascular diseases, which remain a major cause of mortality around the world. In this review, we highlight the options curre...
Amblyopia In Children 3-9 Years Old, With Refractive Anomalies During 2010-2011 In Prishtina
Background. Vision screening in schools has a long history, the reason of which was and continues to be, the treatment of refractive anomalies. Early detection of vision problems has many advantages in education and in e...
Intravitreal Bevacizumab Followed by Ranibizumab for Neovascular Age Related Macular Degeneratıon
Purpose: To compare the outcomes after switching from intravitreal bevacizumab (IVB) to intravitreal ranibizumab (IVR) in patients with neovascular age related macular degeneration (ARMD). Material and Methods: A retrosp...
Photo Documentation In Ocular Trauma
Objective: Aim of the study is to photograph different cases of ocular trauma to ensure the safety of an ophthalmologist in giving prognosis and avoiding problems which are faced in court of law in criminal cases. Study...
Multipotent Mesenchymal Stromal Cells Derived from the Bone Marrow Transported Over 12 Hours Change Their Main Characteristics
Multipotent Mesenchymal Stromal Cells Derived from the Bone Marrow Transported Over 12 Hours Change Their Main Characteristics